Management of Septic Shock in a Bladder Cancer Patient: A Nursing Perspective

QUESTION

Your patient is a 42-year-old female that arrives in the ED with complaints of fever and not feeling well. She is currently undergoing chemotherapy for bladder cancer. She has an indwelling urinary catheter with scant amount of dark, foul smelling urine. She has a temperature of 102.2F, HR 136, BP 110/50 and RR 28. She is allergic to penicillin and Sulfa.

• What type of shock is she experiencing?
• What interventions do you anticipate the doctor will order?
• What can you teach this patient about prevention of infection?
• The doctor orders Bactrim. What should you be concern about? Why?

ANSWER

Management of Septic Shock in a Bladder Cancer Patient: A Nursing Perspective

Introduction

The 42-year-old female patient presenting to the ED with fever and feeling unwell is undergoing chemotherapy for bladder cancer. She has an indwelling urinary catheter with foul-smelling urine and exhibits signs of systemic infection. This essay discusses the type of shock the patient is experiencing, anticipated doctor’s interventions, infection prevention education, and concerns regarding the prescribed medication.

Type of Shock

The patient is likely experiencing septic shock. The combination of fever, tachycardia, hypotension, and tachypnea indicates a systemic inflammatory response to a severe infection. Her indwelling urinary catheter and dark, foul-smelling urine raise concern for a urinary tract infection, which can progress to sepsis, leading to septic shock.

Anticipated Interventions

Fluid Resuscitation:
The doctor is likely to order intravenous fluids to restore blood pressure and tissue perfusion. Fluid resuscitation aims to improve cardiac output and prevent organ failure.

Broad-Spectrum Antibiotics:
Given the patient’s signs of systemic infection and her allergies to penicillin and sulfa, the doctor may prescribe broad-spectrum antibiotics like Bactrim (trimethoprim/sulfamethoxazole) to target potential causative pathogens.

Source Control:
The doctor may request further investigations to identify the source of infection, such as blood cultures, urine analysis, and culture to guide appropriate management.

Infection Prevention Education

Proper Catheter Care:
The patient should be educated on maintaining strict aseptic technique when handling her indwelling urinary catheter. Hand hygiene before and after catheter manipulation is crucial to prevent introducing bacteria into the urinary tract.

Fluid Intake:
Encouraging increased fluid intake helps flush out the urinary tract, reducing the risk of infection. The patient should aim for adequate hydration, but any change in fluid balance should be discussed with her healthcare team.

Signs of Infection:
Teach the patient to recognize signs of infection, such as fever, chills, foul-smelling urine, or changes in urine color or consistency, and promptly report them to her healthcare provider.

Concerns Regarding Bactrim

Bactrim contains sulfa, to which the patient is allergic. This raises concern for an allergic reaction, which can range from mild rashes to severe anaphylaxis. As the patient has a history of sulfa allergy, close monitoring for any signs of hypersensitivity is essential. In case of an allergic reaction, prompt intervention, including stopping the medication and providing appropriate treatment, is crucial to ensure patient safety.

Conclusion

The 42-year-old female patient with bladder cancer presenting with fever and systemic signs of infection is likely experiencing septic shock. Timely and appropriate interventions, such as fluid resuscitation, broad-spectrum antibiotics like Bactrim, and source control, are vital to manage the condition. Additionally, educating the patient about infection prevention measures, especially proper catheter care and recognizing signs of infection, will empower her to take an active role in her care and recovery. Close monitoring for any adverse reactions to Bactrim is essential, considering her allergy history, to ensure her safety and optimize treatment outcomes.